Status:
RECRUITING
Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Bone Metastases
Eligibility:
All Genders
18+ years
Brief Summary
To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of diseas...
Eligibility Criteria
Inclusion
- Patients of either sex of age or older who are candidates for embolization therapy
- Life expectancy \> 3 months
- Single metastatic or oligometastatic.
- Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture
Exclusion
- Patients with life expectancy \<3 months or severe functional status impairment (ASA 4)
- Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC.
- Patients with coagulation deficiency or plateletopenic patients.
- Patients with documented active infection.
Key Trial Info
Start Date :
May 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 10 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06189079
Start Date
May 10 2023
End Date
May 10 2026
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy, 40136